Kaiser Health News
Untold numbers of employers, employees and citizens are turning to a slew of sometimes pricey new COVID-19 blood tests. But serious questions about the accuracy and usefulness of some of them.
After nearly two months at home due to the COVID-19 pandemic, Erica Schoenradt was making plans in May to see her dentist for a checkup.
As states relax coronavirus restrictions, older adults are advised, in most cases, to keep sheltering in place. But for some, the burden of isolation and uncertainty is becoming hard to bear.
After she landed in the hospital with a broken hip, Parkinson’s disease and the coronavirus, 84-year-old Dorothy “Poogie” Wyatt Shields made a request of her children: “Bring me home.”
If there is a silver lining to the flawed U.S. response to the coronavirus pandemic, it is this: The relatively high number of new cases being diagnosed daily — upward of 20,000 — will make it easier to test new vaccines.
On Day Two of the San Francisco Bay Area’s stay-at-home orders in March, Nohemi Jimenez got into her car in San Pablo, California, waved goodbye to her 3-year-old son and drove to her regular Wednesday dialysis appointment.
Johnson & Johnson researchers working on a vaccine against the coronavirus are “just like the heroes in the hospitals” fighting to save patients, J&J CEO Alex Gorsky said on the “Today” show a few weeks ago.
Officials said little about race early in the pandemic. If they had, could it have made a difference?
Last month, Minna Buck revised a document specifying her wishes should she become critically ill.
“No intubation,” she wrote in large letters on the form, making sure to include the date and her initials.